The Valley Desk

NCT04111536 · Interventional trial

Developing Oral LT3 Therapy for Heart Failure - HFpEF

Overall registry status Completed

Phase 1 · Phase 2

Conditions Heart Failure With Preserved Ejection Fraction, Low Triiodothyronine Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov